ARCHIVES

Galeterone Shows Potential In CRPC AR Variants, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

FDA To Regulate Products From Human Cells, Tissue

March 21, 1997

Neutron Therapy Contracts Wind Down Next Year; DCT To Consider Whether To Continue Support

March 25, 1988

Ethics Commission Acknowledges Weak Case For Mandatory Patient Compensation

April 23, 1982

Guttmacher Named NICHD Director

December 18, 2009

Univ. Of Pittsburgh Plans Molecular Medicine Institute.

January 25, 2002

DCE Board Approves Recompetition Concepts

March 18, 1988